Gemmer Asset Management’s DT Midstream DTM Stock Holding History

Gemmer Asset Management’s Portfolio DTM Stock Details DTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-64	Closed	-$3K	–	378
2022 Q1	$3K	Hold	64	–	–	﹤0.01%	1066
2021 Q4	$3K	Hold	64	–	–	﹤0.01%	1111
2021 Q3	$3K	Buy	+64	New	+$2.8K	﹤0.01%	1108

Other funds holding DTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

EIP

Energy Income Partners Westport, Connecticut $6.36B AUM 17.8% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking Tokyo, Japan $45.7B AUM 34.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return

Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

KACA

Kayne Anderson Capital Advisors Los Angeles, California $5.1B AUM 17.16% 1-Year Est. Return

Gemmer Asset Management's DTM Position: Q2 2022 in Review

Gemmer Asset Management sold out of DT Midstream (DTM) in Q2 2022, closing a stake of 64 shares — an estimated $3K sold.

Gemmer Asset Management first reported a position in DTM in Q3 2021 and held it in 3 quarters. The position peaked at $3K in Q1 2022. 407 funds tracked by Wall St. Rank hold DTM as of Q2 2022.

Gemmer Asset Management reported no remaining DT Midstream position as of Q2 2022 after selling out during the quarter.
Gemmer Asset Management sold 64 DT Midstream shares in Q2 2022, an estimated $3K.
Gemmer Asset Management first reported a position in DT Midstream in Q3 2021 and held it in 3 quarters.
Gemmer Asset Management's DT Midstream position peaked at $3K in Q1 2022.
407 funds tracked by Wall St. Rank held DT Midstream as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.